Potential medical risks for autism stem cell therapy in Thailand include systemic immune reactions and gastrointestinal distress. Patients may also experience neurological changes like temporary irritability. Severe risks include tumours, infections from poor lab standards, and immune rejection when using donor cells.
- Immune reactions: Low-grade fever, chills, and fatigue may follow intravenous stem cell infusions.
- Neurological shifts: Temporary spikes in hyperactivity or aggression can last up to 3 months.
- Gastrointestinal issues: Nausea, vomiting, and constipation are commonly reported side effects after treatment.
- Severe complications: Uncontrolled cell division can lead to malignant tumours or abnormal tissue growth.
- Lab risks: Flawed cryobanking protocols may introduce dangerous pathogens directly into the bloodstream.
Bookimed Expert Insight: Many clinics offer stem cell therapy. Australian patients should look for GMP-certified facilities. For example, Panacee Hospital Rama 2 and The Demarest Clinic use AABB-certified processes for cell preservation. These certifications provide a verifiable standard for cell purity and laboratory safety.
Patient Consensus: Families in Thailand recommend asking for specific sterile testing results to avoid infection risks. Most emphasise that while physical pain is short-term, observing long-term safety requires independent evidence.